Literature DB >> 23137520

Routine left atrial appendage ligation during cardiac surgery may prevent postoperative atrial fibrillation-related cerebrovascular accident.

Ryan Kim1, Norbert Baumgartner, John Clements.   

Abstract

OBJECTIVE: The aim of the study was to determine whether routine left atrial appendage ligation in cardiac surgery would reduce the risk of postoperative atrial fibrillation-related cerebrovascular accident.
METHODS: We performed an institutional review board-approved, case-control, retrospective chart review of adult patients who underwent cardiac surgery by a single surgeon between January 1, 2001, and December 31, 2010. Preoperative CHADS(2) score criteria were collected, and outcomes through postoperative day 30 were analyzed.
RESULTS: A total of 2067 patients were reviewed. Propensity score matching was used to create matched groups based on left atrial appendage ligation, and 631 patients were matched in each group. Subjects with postoperative atrial fibrillation were 2.4 times (95% confidence interval, 1.51-2.82) more likely to undergo valve surgery, 2.11 times (95% confidence interval, 1.56-2.86) more likely to be aged more than 75 years, and 1.36 times (95% confidence interval, 1.03-1.80) more likely to have undergone left atrial appendage ligation. In the left atrial appendage ligation group with postoperative atrial fibrillation (n = 145), there were zero subjects (0%) with a postoperative cardiovascular accident. In the non-left atrial appendage ligation group with postoperative atrial fibrillation (n = 115), there were 7 subjects (6.1%) with a postoperative cardiovascular accident (0.0% vs 6.1%, P = .003).
CONCLUSIONS: Although postoperative atrial fibrillation remains a common complication of cardiac surgery, there was a significant decrease in the incidence of postoperative cerebrovascular accidents since routine ligation of the left atrial appendage was undertaken. This has been found to be a safe adjunct to a wide variety of cardiac procedures and therefore deserves further study by a larger randomized controlled trial.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23137520     DOI: 10.1016/j.jtcvs.2012.10.016

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  Left atrial appendage exclusion for atrial fibrillation: does the protection from stroke prevail in the long-term?

Authors:  Vaibhav R Vaidya; Roshini Asirvatham; Jason Tri; Samuel J Asirvatham
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 2.  Dual inflow, total-arterial, anaortic, off-pump coronary artery bypass grafting: how to do it.

Authors:  Fabio Ramponi; Michael Seco; James B Edelman; Andrew G Sherrah; Paul G Bannon; R John L Brereton; Michael K Wilson; Michael P Vallely
Journal:  Ann Cardiothorac Surg       Date:  2018-07

3.  Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 Patients.

Authors:  Rowlens M Melduni; Hartzell V Schaff; Hon-Chi Lee; Bernard J Gersh; Peter A Noseworthy; Kent R Bailey; Naser M Ammash; Stephen S Cha; Kaniz Fatema; Waldemar E Wysokinski; James B Seward; Douglas L Packer; Charanjit S Rihal; Samuel J Asirvatham
Journal:  Circulation       Date:  2016-11-30       Impact factor: 29.690

Review 4.  Left atrial appendage exclusion for atrial fibrillation.

Authors:  Faisal F Syed; Christopher V DeSimone; Paul A Friedman; Samuel J Asirvatham
Journal:  Cardiol Clin       Date:  2014-10-23       Impact factor: 2.213

5.  Evaluation of anticoagulation use and subsequent stroke in patients with atrial fibrillation after empiric surgical left atrial appendage closure: A retrospective case-control study.

Authors:  Daniel O Johnsrud; Rowlens M Melduni; Brian Lahr; Xiaoxi Yao; Kevin L Greason; Peter A Noseworthy
Journal:  Clin Cardiol       Date:  2018-12-10       Impact factor: 2.882

Review 6.  Optimization Of Stroke Prophylaxis Strategies In Nonvalvular AF -Drugs, Devices Or Both?

Authors:  Amit Noheria; Faisal F Syed; Christopher V DeSimone; Samuel J Asirvatham
Journal:  J Atr Fibrillation       Date:  2015-08-31

7.  ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training.

Authors:  Gavino Casu; Michele Massimo Gulizia; Giulio Molon; Patrizio Mazzone; Andrea Audo; Giancarlo Casolo; Emilio Di Lorenzo; Michele Portoghese; Christian Pristipino; Renato Pietro Ricci; Sakis Themistoclakis; Luigi Padeletti; Claudio Tondo; Sergio Berti; Jacopo Andrea Oreglia; Gino Gerosa; Marco Zanobini; Gian Paolo Ussia; Giuseppe Musumeci; Francesco Romeo; Roberto Di Bartolomeo
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

8.  Surgical left atrial appendage occlusion during cardiac surgery: A systematic review and meta-analysis.

Authors:  Varunsiri Atti; Mahesh Anantha-Narayanan; Mohit K Turagam; Scott Koerber; Sunil Rao; Juan F Viles-Gonzalez; Rakesh M Suri; Poonam Velagapudi; Dhanunjaya Lakkireddy; David G Benditt
Journal:  World J Cardiol       Date:  2018-11-26

9.  Role of left atrial appendage occlusion in patients with HeartMate 3.

Authors:  Andrew Melehy; Gillian O'Connell; Yuming Ning; Paul Kurlansky; Yuji Kaku; Veli Topkara; Melana Yuzefpolskaya; Paolo C Colombo; Gabriel Sayer; Nir Uriel; Yoshifumi Naka; Koji Takeda
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-03-31

10.  Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score.

Authors:  Giovanni Mariscalco; Fausto Biancari; Marco Zanobini; Marzia Cottini; Gabriele Piffaretti; Matteo Saccocci; Maciej Banach; Cesare Beghi; Gianni D Angelini
Journal:  J Am Heart Assoc       Date:  2014-03-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.